Serco makes gains with $900mn Medicare and Medicaid Contract
Leading provider of professional, technology, and management services, Serco has recently revealed that is has been awarded a $900mn contract from the US Department of Health and Human Services, Center for Medicare and Medicaid Services (CMS)
The contract will enable Serco to continue supporting eligibility determinations for consumers purchasing health insurance through Federal Health Insurance Exchanges. The contract has a one-year base period and four one-year option periods.
Serco will assist qualified consumers to effectively and efficiently verify their eligibility for benefits. Work for the Company under the contract includes continued development of the Eligibility Support platform involving the processing of a wide variety of consumer transactions. Serco services ensure the integrity of the programme while assisting qualified consumers in securing and maintaining their eligibility to enrol in a Qualified Health Plan.
- Fortune 500 startup Fortive Corporation acquires a Johnson & Johnson division for $2.8bn
- Tackling the demands of a digital world in an analogue healthcare industry
- Best Buy is set to enter the healthcare space
"Since 2013, Serco has developed a great working partnership with CMS to provide vital services to consumers applying for health insurance eligibility," said Dave Dacquino, Chairman and Chief Executive Officer of Serco Inc.
"As we move forward, Serco is committed to continuing to deliver our case management expertise in support of program integrity."
Over the past five years, Serco has assisted millions of consumers in adjudicating their eligibility applications using a combination of skilled staff and process automation to drive down costs and protect programme integrity. Under this contract, the Serco Eligibility Support team will continue to enhance their automated processing platforms and their staff expertise in providing even better and more efficient consumer service.
The Company plans to maintain its processing centers in London, Kentucky; Rogers, Arkansas, and Lawton, Oklahoma.
A third of UK patients prefer mobile apps to doctor visits
A third of UK patients prefer using mobile healthcare applications to having face-to-face consultations, a new report has found.
The research, commissioned by Mobiquity and conducted by Censuswide, surveyed 100 doctors and 1,003 patients in the UK during COVID-19 to understand their experiences with digital healthcare technology and its impact on patient care.
It found that as a result of COVID-19, 33% of patients would rather use a mobile app than visit the doctor.
Additionally over a third of doctors said that using mobile healthcare applications made it easier to prescribe the right treatment for patients remotely. However respondents cited technical issues and privacy concerns as barriers to using mobile healthcare apps.
The survey's other findings include:
* 56% of UK patients plan to use mobile healthcare applications in the future after using them during COVID-19.
* 71% of doctors plan to adopt mobile healthcare applications in the future
*52% of doctors experienced technical issues, with device compatibility problems being the most frequently reported technical issue
*28% of patients cited privacy concerns when using mobile healthcare applications during COVID-19
Commenting on the report, Teun Schutte, Managing Consultant at Mobiquity said that the COVID-19 pandemic had been transformational for digital healthcare. "The pandemic has shown the importance of digital health solutions and the need for increased adoption in the future, while at the same time highlighting the benefits around ease of access to care for patients and lower costs for healthcare providers.
“The challenge that exists, however, is how to solve frictions in the delivery of mobile healthcare applications and other types of digital health in the future. Our research highlighted the main barriers to adoption for patients and practitioners, and the areas we need to optimise to ensure digital innovation is scaled successfully to improve patient outcomes. Indeed, technical issues and privacy concerns need to be solved by aligning stakeholder concerns before digital health products are launched" he added.
“By aligning the digital innovation process and creating a blueprint for scaling the next generation of digital health technologies, as an industry we can scale digital health products or services across disease areas, and across hospitals, markets and regions, ensuring that patients receive personalised, quality care through digital health technologies.”